PT Siloam International Hospitals (SILO) Q2 2026 earnings summary

Executive summary

• Revenue for the six months ended June 30, 2026, reached Rp6,763,399 million, up from Rp6,104,948 million year-over-year.

• Net profit for the period was Rp609,453 million, a significant increase from Rp476,418 million in the prior year.

• Gross profit improved to Rp2,580,592 million from Rp2,300,141 million year-over-year.

• Earnings per share (EPS) rose to Rp44.71 from Rp35.18 year-over-year.

Financial highlights

• Operating income for the period was Rp869,577 million, up from Rp710,847 million year-over-year.

• Total assets as of June 30, 2026, were Rp15,832,534 million, compared to Rp14,498,064 million at December 31, 2025.

• Total equity increased to Rp10,543,143 million from Rp9,928,969 million at year-end 2025.

• Cash and cash equivalents stood at Rp1,226,974 million, up from Rp1,159,893 million at year-end.

• Net cash from operating activities was Rp801,507 million for the six months, up from Rp789,010 million year-over-year.

Outlook and guidance

• Management continues to focus on expanding hospital operations and maintaining strong financial discipline.

• Ongoing investments in property, equipment, and technology are expected to support future growth.